Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Diabetes

NCT01637935 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01637935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01637935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Diabetes
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
July 31, 2004
Completion date
August 31, 2014
Enrollment
193,099 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, diabetes